Showing results (2111-2120 of 2,226) with videos related to
Sort By:
Pageof 223
Nature Communications|June 18, 2024
Epistasis mediates the evolution of the receptor binding mode in recent human H3N2 hemagglutininRuipeng Lei, Weiwen Liang, Wenhao O Ouyang, et al.Frontiers in Immunology|October 9, 2023
Control of maternal Zika virus infection during pregnancy is associated with lower antibody titers in a macaque modelNicholas P Krabbe, Elaina Razo, Hunter J Abraham, et al.Nature Communications|June 22, 2026
Structural basis for distinct protective mechanisms of IGHV3-23 antibodies targeting influenza hemagglutinin stemHuibin Lv, Yang Wei Huan, Tossapol Pholcharee, et al.JACC. Asia|September 5, 2025
Addressing Frailty in Cardiology: Identifying Barriers Faced by Cardiologists and Health Care Professionals in AsiaJie Jun Wong, Rilong Hong, Terence Ing Wei Ong, et al.Plos One|November 19, 2016
Findings on Thoracic Computed Tomography Scans and Respiratory Outcomes in Persons with and without Chronic Obstructive Pulmonary Disease: A Population-Based Cohort StudyWan C Tan, Cameron J Hague, Jonathon Leipsic, et al.Acta Medica Philippina|October 14, 2024
Health Benefit Utilization and Out-of-Pocket Expenses in Outpatient Care and Hospitalizations: Baseline Surveys of Three Primary Care Sites in the PhilippinesLeonila F Dans, Jose Rafael A Marfori, Regine Ynez H De Mesa, et al.Journal of the American Heart Association|September 30, 2023
Developing Clinical Risk Prediction Models for Worsening Heart Failure Events and Death by Left Ventricular Ejection FractionRishi V Parikh, Alan S Go, Ankeet S Bhatt, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 20, 2020
An overview of frailty in kidney transplantation: measurement, management and future considerationsMeera N Harhay, Maya K Rao, Kenneth J Woodside, et al.Circulation Research|December 30, 2020
Single-Cell Analysis of Blood-Brain Barrier Response to Pericyte LossMaarja A Mäe, Liqun He, Sofia Nordling, et al.Targeted Oncology|April 15, 2023
A Phase I, First-in-Human Study of PRL3-zumab in Advanced, Refractory Solid Tumors and Hematological MalignanciesCheng E Chee, Melissa Ooi, Soo-Chin Lee, et al.Pageof 223